Treatment with loncastuximab tesirine-lpyl was associated with the development of dermatologic adverse events (dAEs) in 20% of patients with relapsed or refractory diffuse large B‑cell lymphoma; these ...
Nodular sclerosis Hodgkin lymphoma frequently presents with chest or neck adenopathy and characteristic fibrous bands on histology, and remains highly curable despite advanced-stage presentations.
Patients with early-stage Hodgkin lymphoma had impressive response rates when treated with a novel combination of therapies—brentuximab vedotin and nivolumab combined with chemotherapy drugs ...
A 25-year-old woman says a GP “laughed” at her when she suggested she might have cancer, but later discovered she had Hodgkin lymphoma. Kelly Underwood, from Birmingham, first presented with lethargy, ...
In mantle cell lymphoma (MCL), an aggressive form of B-cell non-Hodgkin lymphoma, TP53 mutations are known to affect patients’ prognosis—but questions remain. What does the heterogeneity of TP53 ...
Hodgkin’s lymphoma is definitively diagnosed by the presence of Reed-Sternberg cells, whereas Non-Hodgkin’s lymphoma involves a wider range of lymphoid variations and is classified based on cell ...
Please provide your email address to receive an email when new articles are posted on . The addition of epcoritamab to rituximab and lenalidomide improved PFS and response rate. The regimen is a ...
Thanks to a clinical trial for follicular lymphoma at MSK, Michael is able to spend time with family, including his granddaughter, Natalia. Retired New York City police officer Michael T. had grown ...
Credit: Citius Oncology. Lymphir is supplied as a 300mcg lyophilized cake in a single-dose vial for reconstitution and further dilution. The prescribing information for Lymphir includes a boxed ...
Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? In a recent Instagram post, one prominent New York City dermatologist exposed ...
Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer ...